Cargando…
Mesoporous Silica Nanoparticle-Based Imaging Agents for Hepatocellular Carcinoma Detection
Hepatocellular carcinoma (HCC) is characterized by poor prognosis and high mortality. The treatment of HCC is closely related to the stage, and the early-stage of HCC patients usually accompanies a more long-term survival rate after clinical treatment. Hence, there are critical needs to develop effe...
Autores principales: | Peng, Xuqi, Lin, Gan, Zeng, Yun, Lei, Zhao, Liu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635232/ https://www.ncbi.nlm.nih.gov/pubmed/34869261 http://dx.doi.org/10.3389/fbioe.2021.749381 |
Ejemplares similares
-
Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
por: Wu, Han, et al.
Publicado: (2021) -
Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
por: Tao, Yaoye, et al.
Publicado: (2020) -
Efficient Photoacoustic Imaging With Biomimetic Mesoporous Silica-Based Nanoparticles
por: Huang, Chuangjia, et al.
Publicado: (2021) -
Biocompatible Mesoporous Silica–Polydopamine Nanocomplexes as MR/Fluorescence Imaging Agent for Light-Activated Photothermal–Photodynamic Cancer Therapy In Vivo
por: Lu, Jiahui, et al.
Publicado: (2021) -
Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy
por: Chaudhary, Zanib, et al.
Publicado: (2019)